Centese, Inc.

Centese is a medical technology company specializing in intelligent digital solutions for post-operative surgical drainage in cardiothoracic surgery. Founded in 2015 and based in Omaha, Nebraska, Centese develops FDA-cleared systems that enhance patient safety and clinical decision-making following cardiac and thoracic procedures. The company's flagship product, Thoraguard, is an automated chest tube management system that addresses critical challenges in post-operative recovery, including drainage complications, extended hospital stays, and labor-intensive nursing workflows. Thoraguard delivers real-time monitoring of drainage volume and air leak rates with 24-hour trend analysis, features the first and only automated clog clearance system for chest tubes, and provides digital alerts for unexpected disruptions. The system is designed as a compact, all-in-one platform for both cardiac and thoracic surgical populations. Centese has treated nearly 15,000 patients and is expanding across U.S. hospitals with plans to enter the European market.